NUCB2 and cancer: In addition to its involvement in energy regulation, NUCB2 has been identified as a negative prognostic indicator in several cancer types, including breast cancer, colon cancer, bladder cancer, prostate cancer, endometrial cancer, gastric cancer, papillary thyroid cancer, and renal cell carcinoma [15,16,17].